Kwality Pharmaceuticals Limited - Laporan Laba Rugi (TTM)

Kwality Pharmaceuticals Limited
IN ˙ BSE
₹ 751.10 ↓ -3.90 (-0.52%)
2025-04-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Kwality Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,897 2,266 2,631 3,232 4,473 4,634 4,562 4,062 2,799 2,480 2,510 2,483 2,621 2,840 3,072 3,198 3,402 3,465 3,702 4,016
Change (%) 19.47 16.08 22.86 38.40 3.59 -1.55 -10.96 -31.08 -11.43 1.24 -1.10 5.58 8.35 8.16 4.11 6.37 1.86 6.84 8.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,205 1,476 1,716 1,878 2,088 2,139 2,051 1,800 1,420 1,122 1,136 1,072 1,261 1,453 1,580 1,591 1,738 1,726 1,825 2,015
Change (%) 22.46 16.29 9.47 11.17 2.42 -4.08 -12.24 -21.10 -21.01 1.23 -5.62 17.66 15.23 8.72 0.72 9.19 -0.70 5.76 10.42
% of Revenue 63.52 65.11 65.23 58.12 46.68 46.15 44.97 44.32 50.74 45.25 45.25 43.18 48.12 51.18 51.44 49.76 51.08 49.80 49.29 50.18
Gross Operating Profit 692 791 915 1,354 2,385 2,495 2,511 2,262 1,379 1,358 1,375 1,411 1,360 1,387 1,492 1,607 1,664 1,739 1,877 2,001
Change (%) 14.27 15.69 47.97 76.19 4.62 0.62 -9.91 -39.03 -1.56 1.25 2.63 -3.61 1.98 7.57 7.71 3.58 4.53 7.91 6.60
% of Revenue 36.48 34.89 34.77 41.88 53.32 53.85 55.03 55.68 49.26 54.75 54.75 56.82 51.88 48.82 48.56 50.24 48.92 50.20 50.71 49.82
SG&A 162 146 160 167 179 191 203 222 262 281 301 316 317 316 326 347 371 402 438 462
Change (%) -9.81 9.89 4.50 6.79 7.14 5.93 9.71 17.78 7.40 7.06 4.91 0.15 -0.12 3.21 6.22 7.06 8.25 9.01 5.55
% of Revenue 8.52 6.43 6.09 5.18 3.99 4.13 4.44 5.48 9.36 11.35 12.00 12.73 12.08 11.13 10.62 10.84 10.91 11.59 11.83 11.51
R&D
Change (%)
% of Revenue
OpEx 1,728 2,061 2,394 2,585 3,078 3,077 2,935 2,764 2,167 1,950 2,044 2,060 2,232 2,445 2,587 2,670 2,828 2,880 3,062 3,314
Change (%) 19.24 16.14 7.99 19.06 -0.02 -4.63 -5.83 -21.59 -10.02 4.80 0.81 8.34 9.55 5.82 3.20 5.93 1.84 6.30 8.23
% of Revenue 91.12 90.95 90.99 79.98 68.81 66.41 64.33 68.04 77.41 78.64 81.40 82.98 85.15 86.08 84.23 83.49 83.14 83.13 82.71 82.52
Operating Income 168 205 237 647 1,395 1,556 1,627 1,298 632 530 467 423 389 395 485 528 573 585 640 702
Change (%) 21.79 15.48 173.08 115.69 11.54 4.54 -20.21 -51.29 -16.24 -11.86 -9.46 -7.88 1.51 22.61 8.97 8.62 1.94 9.51 9.67
% of Revenue 8.88 9.05 9.01 20.02 31.19 33.59 35.67 31.96 22.59 21.36 18.60 17.02 14.85 13.92 15.77 16.51 16.86 16.87 17.29 17.48
Interest Expense -23 -25 -27 -28 -29 -26 -29 -35 -41 -55 -60 -70 -82 -90 -104 -107 -110 -104 -99 -102
Change (%) 8.63 7.94 3.01 4.13 -8.31 10.88 18.53 17.16 35.76 9.46 16.05 17.58 9.54 15.43 2.81 2.77 -4.85 -5.40 2.86
% of Revenue -1.20 -1.09 -1.02 -0.85 -0.64 -0.57 -0.64 -0.85 -1.45 -2.22 -2.40 -2.81 -3.13 -3.17 -3.38 -3.34 -3.23 -3.01 -2.67 -2.53
Net Income 110 131 151 460 1,022 1,139 1,200 962 456 369 194 143 115 120 238 267 290 298 398 434
Change (%) 18.74 15.78 203.74 122.08 11.53 5.31 -19.83 -52.61 -19.06 -47.49 -26.39 -19.59 4.39 98.79 12.33 8.36 2.90 33.69 8.96
% of Revenue 5.81 5.77 5.76 14.23 22.84 24.59 26.30 23.68 16.28 14.88 7.72 5.74 4.38 4.22 7.75 8.36 8.51 8.60 10.76 10.81

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista